cn3
Wednesday 23 November 2016
Lilly Alzheimer's Drug Can Save Dismal Year for Pharma
Upcoming Alzheimer’s disease results from Eli Lilly will have major impact on biotech and pharma stocks.
from WSJ.com: Markets http://ift.tt/2f4pv3B
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment